• 1
    Fleisch H 1991 Bisphosphonates: Pharmacology and use in the treatment of tumor-induced hypercalcaemic and metastatic bone disease Drugs 42:919944.
  • 2
    Fleisch H 1997 Bisphosphonates in Bone Disease, 3rd Ed. The Parthenon Publishing Group, New York, NY, U.S.A.
  • 3
    Plosker GL, Gao KL 1994 Clodronate: A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease Drugs 47:945982.
  • 4
    Russell RG, Smith R, Preston C, Walton RJ, Woods CG 1974 Disphosphonates in Paget's disease Lancet 1:894898.
  • 5
    Storm T, Thamsborg G, Steiniche T, Genant HK, Soerensen OH 1990 Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis N Engl J Med 322:12651271.
  • 6
    Fleisch H 1993 New bisphosphonates in osteoporosis Osteoporos Int 3(Suppl 2):S15S22.
  • 7
    Khan SA, McCloskey EV, Eyres KS, Nakatsuka K, Sirtori P, Orgee J, Coombes G, Kanis JA 1996 Comparison of three intravenous regimens of clodronate in Paget disease of bone J Bone Miner Res 11:178182.
  • 8
    Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC, Yanover MJ, Mysiw WJ, Kohse L, Rao MB, Steiger P, Richmond B, Chestnut CH 1990 Intermittent cyclical etidronate treatment of postmenopausal osteoporosis N Engl J Med 323:7379.
  • 9
    Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE 1996 Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Lancet 348:15351541.
  • 10
    Fitton A, McTavish D 1991 Pamidronate: A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease Drugs 41:289318.
  • 11
    Mugglestone CJ 1985 Etidronate and risk of fractures Lancet 1:1393.
  • 12
    Tarvainen R, Olkkonen H, Nevalainen T, Hyvonen P, Arnala I, Alhava E 1994 Effect of clodronate on fracture healing in denervated rats Bone 15:701705.
  • 13
    Nyman MT, Paavolainen P, Lindholm TS 1993 Clodronate increases the calcium content in fracture callus Arch Orthop Trauma Surg 112:228231.
  • 14
    Nyman MT, Gao T, Lindholm TC, Lindholm TS 1996 Healing of a tibial double osteotomy is modified by clodronate administration: An experimental study Arch Orthop Trauma Surg 115:111114.
  • 15
    Chastagnier D, Barbier A, de Vernejonl MC, Geusens P, Lacheret F 1993 Effect of two bisphosphonates (tiludronate and etidronate) on bone healing J Bone Miner Res 8:S236.
  • 16
    Flora L, Hassing GS, Cloyd GG, Bevan JA, Parfitt AM, Villanueva AR 1981 The long term skeletal effects of EHDP in dogs Metab Bone Dis Rel Res 3:289300.
  • 17
    Lenehan TM, Balligand M, Nunamaker DM, Wood FE 1985 Effect of EHDP on fracture healing in dogs J Orthop Res 3:499507.
  • 18
    Peter CP, Cook WO, Nunamaker DM, Provost MT, Seedor JG, Rodan GA 1996 Effect of alendronate on fracture healing and bone remodeling in dogs J Orthop Res 14:7479.
  • 19
    McKibbin B 1978 The biology of fracture healing in long bones J Bone Joint Surg 60B:150162.
  • 20
    Schenk RK, Hunziker EB 1994 Histologic and ultrastructural features of fracture healing. In: BrightonCT, FriedlaenderGE, LaneJM (eds.) Bone Regeneration and Repair, 1st Ed. American Academy of Orthopaedic Surgeons, Rosemont, IL, U.S.A., pp. 117146.
  • 21
    Einhorn TA 1998 The cell and molecular biology of fracture healing Clin Orthop 355S:S7S21.
  • 22
    Aro HT, Wippermann BW, Hodgson SF, Chao EY 1990 Internal remodeling of periosteal new bone during fracture healing J Orthop Res 8:238246.
  • 23
    Einhorn TA, Hirschman A, Kaplan C, Nashed R, Devlin VJ, Warman J 1989 Neutral protein-degrading enzymes in experimental fracture callus: A preliminary report J Orthop Res 7:792805.
  • 24
    Northmore Ball MD, Wood MR, Meggitt BF 1980 A biomechanical study of the effects of growth hormone in experimental fracture healing J Bone Joint Surg 62B:391396.
  • 25
    Welch RD, Birch JG, Makarov MR, Samchukov ML 1998 Histomorphometry of distraction osteogenesis in a caprine tibial lengthening model J Bone Miner Res 13:19.
  • 26
    Usui T, Watanabe T, Higuchi S 1995 Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs Drug Metab Dispos 23:12141219.
  • 27
    Nishikawa M, Akatsu T, Katayama Y, Yasutomo Y, Kado S, Kugai N, Yamamoto M, Nagata N 1996 Bisphosphonates act on osteoblastic cell and inhibit osteoclast formation in mouse marrow cultures Bone 18:914.
  • 28
    Hiraga T, Tanaka S, Yamamoto M, Nakajima T, Ozawa H 1996 Inhibitory effects of bisphosphonate (YM-175) on bone resorption induced by a metastatic bone tumor Bone 18:17.
  • 29
    Li J, Mori S, Mashiba T, Kaji Y, Taki M, Komatsubara S, Kawanishi J, Norimatsu H 1998 Preadministration of incadronate disodium can prevent bone loss in rat proximal tibial metaphysis when induced by hindlimb immobilization by bandage Bone 23:459463.
  • 30
    Frost HM 1988 The biology of fracture healing Clin Orthop 248:283309.
  • 31
    Murakami H, Takahashi N, Sasaki T, Udagawa N, Tanaka S, Nakamura I, Zhang D, Barbier A, Suda T 1995 A possible mechanism of the specific action of bisphosphonates on osteoclasts: Tiludronate preferentially affects polarized osteoclasts having ruffled borders Bone 17:137144.
  • 32
    Sato M, Grasser W 1990 Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy J Bone Miner Res 5:3140.
  • 33
    Hughes DE, MacDonald BR, Russell RG, Gowen M 1989 Inhibition of osteoclast-like cell formation by bisphosphonates in long-term culture of human bone marrow J Clin Invest 83:19301935.
  • 34
    Fleisch H 1998 Bisphosphonates: mechanisms of action Endocr Rev 19:80100.
  • 35
    Goodship AE, Walker PC, McNally D, Chambers T, Green JR 1994 Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone Ann Oncol 5(Suppl 7):S53S55.
  • 36
    Motoie H, Nakamura T, O'uchi N, Nishikawa H, Kanoh H, Abe T, Kawashima H 1995 Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction J Bone Miner Res 10:910920.
  • 37
    Schenk R, Merz WA, Muhlbauer R, Russell RGG, Fleisch H 1973 Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats Calcif Tissue Res 11:196214.
  • 38
    Black J, Perdigon P, Brown N, Pollack SR 1984 Stiffness and strength of fracture callus Clin Orthop 182:278288.
  • 39
    Bak B, Andreassen TT 1991 The effect of growth hormone on fracture healing in old rats Bone 12:151154.
  • 40
    Bak B, Jensen KS 1992 Standardization of tibial fractures in the rat Bone 13:289295.
  • 41
    Nii A, Fujimoto R, Okazaki A, Narita K, Miki H 1994 Intramembranous and endochondral bone changes induced by a new bisphosphonate (YM175) in the beagle dog Toxicol Pathol 22:536544.
  • 42
    Giuliani N, Pedrazzoni M, Negri G, Passeri G, Impicciatore M, Girasole G 1998 Bisphosphonates stimulate formation of osteoblast precursors and nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo Bone 22:455461.
  • 43
    Parfitt AM 1984 The cellular basis of bone remodeling: The quantum concept reexamined in light of recent advances in the cell biology of bone Calcif Tissue Int 36:S37S45.
  • 44
    Sandberg M, Aro H, Multimäki P, Aho H, Vuorio E 1989 In situ localization of collagen production by chondrocytes and osteoblasts in fracture callus J Bone Joint Surg 71A:6977.
  • 45
    Sandberg M, Vuorio T, Hirvonen H, Alitalo K, Vuorio E 1988 Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones Development 102:461470.
  • 46
    Ruther U, Garber C, Komitowski D, Muller R, Wagner EF 1987 Deregulated c-fos expression interferes with normal bone development in transgenic mice Nature 325:412416.
  • 47
    Linkhart TA, Mohan S, Baylink DJ 1996 Growth factors for bone growth and repair: IGF, TGF beta and BMP Bone 19(Suppl 1):S1S12.
  • 48
    Mundy GR, Yoneda T 1995 Facilitation and suppression of bone metastasis Clin Orthop 312:3444.
  • 49
    Hulth A 1989 Current concepts of fracture healing Clin Orthop 249:265284.
  • 50
    Ekeland A, Engesoeter LB, Langeland N 1982 Influence of age on mechanical properties of healing fractures and intact bones in rats Acta Orthop Scand 53:527534.
  • 51
    Kasting GB, Francis MD 1992 Retention of etidronate in human, dog and rat J Bone Miner Res 7:513522.
  • 52
    Lin JH, Chen IW, Duggan DE 1992 Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats Drug Metab Dispos 20:473478.